METTL3‐mediated m6A mRNA contributes to the resistance of carbon‐ion radiotherapy in non‐small‐cell lung cancer
Open Access
- 9 October 2022
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 114 (1) , 105-114
Abstract
Lung cancer is one of the leading causes of death among cancer patients worldwide. Carbon‐ion radiotherapy is a radical nonsurgical treatment with high local control rates and no serious adverse events. N6‐methyladenosine (m6A) modification is one of the most common chemical modifications in eukaryotic messenger RNA (mRNA) and has important effects on the stability, splicing, and translation of mRNAs. Recently, the regulatory role of m6A in tumorigenesis has been recognized more and more. However, the dysregulation of m6A and its role in carbon‐ion radiotherapy of non‐small‐cell lung cancer (NSCLC) remains unclear. In this study, we found that the level of methyltransferase‐like 3 (METTL3) and its mediated m6A modification were elevated in NSCLC cells with carbon‐ion radiotherapy. Knockdown of METTL3 in NSCLC cells impaired proliferation, migration, and invasion in vitro and in vivo. Moreover, we found that METTL3‐mediated m6A modification of mRNA inhibited the decay of H2A histone family member X (H2AX) mRNA and enhanced its expression, which led to enhanced DNA damage repair and cell survival.Keywords
This publication has 39 references indexed in Scilit:
- The interplay between DNA repair and autophagy in cancer therapyCancer Biology & Therapy, 2015
- Carbon Ion Therapy for Early-Stage Non-Small-Cell Lung CancerBioMed Research International, 2014
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferaseCell Research, 2014
- Double strand break repair functions of histone H2AXMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2013
- Carbon Ion Radiotherapy for Oligo-Recurrence in the LungPulmonary Medicine, 2013
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seqNature, 2012
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTONature Chemical Biology, 2011
- High‐dose proton therapy and carbon‐ion therapy for stage I nonsmall cell lung cancerCancer, 2010
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatinNucleic Acids Research, 2008
- Regulation of DNA double-strand break repair pathway choiceCell Research, 2007